Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Combinatorial Gene Control02:33

Combinatorial Gene Control

9.8K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.8K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seasonal patterns of vegetation drought resilience and vegetation loss in Central Asia.

PloS one·2026
Same author

Apelin-APLNR pathway across development, inflammation, and vascular remodeling: an endothelial perspective.

Experimental & molecular medicine·2026
Same author

Integrating pyrometallurgy and slag design: A novel strategy for enhanced platinum extraction from hybrid wastes (spent automotive catalysts/electric arc furnace dust).

Waste management & research : the journal of the International Solid Wastes and Public Cleansing Association, ISWA·2026
Same author

Generation of Functional Oligodendrocyte Progenitor Cells Through Serial Replating of iPSC-Derived NPC Spheres.

Cells·2026
Same author

PCBP1 orchestrates amino acid metabolism burst during the naïve-to-primed pluripotency transition.

Stem cell reports·2026
Same author

Developmental chronology of mouse embryo from 2-cell stage through birth.

Nature cell biology·2026

Related Experiment Video

Updated: Mar 9, 2026

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
08:01

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells

Published on: August 29, 2020

2.7K

Changing POU dimerization preferences converts Oct6 into a pluripotency inducer.

Stepan Jerabek1, Calista Kl Ng2, Guangming Wu1

  • 1Max Planck Institute for Molecular Biomedicine, Münster, Germany.

EMBO Reports
|December 24, 2016
PubMed
Summary
This summary is machine-generated.

Oct4 and Oct6 transcription factors have different roles in cell reprogramming. A single amino acid change alters their DNA binding and function, revealing how POU factor activity is determined by DNA-dependent dimerization.

Keywords:
DNA bindingOct4POU factorsreprogramming to pluripotency

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
08:01

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells

Published on: August 29, 2020

2.7K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.5K

Area of Science:

  • Molecular biology
  • Stem cell research
  • Genetics

Background:

  • Oct4 is crucial for induced pluripotent stem cells (iPSCs) reprogramming, but other POU factors like Oct6 induce different cell fates.
  • Understanding the molecular basis for Oct4 and Oct6's distinct DNA-binding and functional activities is essential for stem cell biology.

Purpose of the Study:

  • To identify the molecular determinants responsible for the differential DNA-binding and reprogramming activities of Oct4 and Oct6.
  • To elucidate how specific amino acid residues influence POU factor dimerization and target gene recognition.

Main Methods:

  • Re-analysis of ChIP-Seq data to study Oct4 and Oct6 binding patterns.
  • Dimerization assays to assess Oct4 and Oct6 homodimerization and heterodimerization.
  • Structural and biochemical analyses to pinpoint key amino acid residues involved in DNA binding.
  • Site-directed mutagenesis to investigate the functional impact of amino acid substitutions on reprogramming efficiency.

Main Results:

  • Oct6 exhibits more cooperative and stable homodimerization on palindromic DNA elements compared to Oct4.
  • A single amino acid substitution was identified as a key determinant for Oct4 and Oct6 binding to their respective DNA elements.
  • Mutating this residue in Oct4 reduced its iPSC generation capacity, while the reverse mutation in Oct6 did not enhance its reprogramming potential.
  • Further mutations enabled Oct6 to generate iPSCs and maintain pluripotency, highlighting the role of specific residues in POU factor function.

Conclusions:

  • Cell type-specific functions of POU factors are dictated by specific amino acid residues that modulate DNA-dependent dimerization.
  • These findings provide insights into the mechanisms underlying stem cell pluripotency and lineage specification.
  • Targeting these residues could offer novel strategies for controlling cell fate and enhancing reprogramming efficiency.